Expression of NRP-1 and NRP-2 in Endometrial Cancer.

CONCLUSION: NRP1 and NRP2 are candidates for complementary diagnostic molecular markers and promising new targets for molecular, personalized anticancer therapies.
PMID: 30806307 [PubMed - as supplied by publisher]

Source: Current Pharmaceutical Biotechnology - February 19, 2019 Category: Biotechnology Authors: Oplawski M, Dziobek K, Grabarek B, Zmarzly N, Dabrus D, Januszyk P, Brus R, Tomala B, Boron D Tags: Curr Pharm Biotechnol Source Type: research